跳至主要内容
临床试验/NCT00930709
NCT00930709已完成不适用

Botulinum Toxin Versus Active Strength Training in Treatment of the Lateral Epicondylitis - A Single-Blinded, Randomized, Controlled Trial

Seinajoki Central Hospital1 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2009年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
103
试验地点
1
主要终点
Pain, 100 mm visual analogue scale, change from baseline

研究概览

简要总结

The purpose of this study is to compare efficacy, feasibility and cost effectiveness of botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.

The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.

详细描述

INTRODUCTION:

Lateral epicondylitis (tennis elbow) is a frequent repetitive stress injury, affecting the common extensor muscles at the lateral humeral epicondyle. Lateral epicondylitis has a well-known spontaneous healing tendency. Still the prevalence of the chronic lateral epicondylitis is 1.4% in working populations causing significant occupational disability and financial burden.

Systematic reviews of the effectiveness of different treatment modalities for lateral epicondylitis present conflicting results. There are no consistent guidelines for management of the prolonged lateral epicondylitis. Progressive strengthening and stretching exercises as well as botulinum toxin type A injections have been suggested to be effective in treatment of chronic cases. However, there are only a few studies comparing different treatment modalities and botulinum toxin treatment have not been included in any of these.

The purpose of this study is to compare efficacy, feasibility and cost effectiveness of the botulinum toxin type A injections to active nine weeks strength training and stretching program in the treatment of the chronic lateral epicondylitis.

The main hypothesis is that the botulinum toxin type A injections may enable more rapid pain relief while strength training may provide better functional results and less relapses during the follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •pain at the lateral side of the elbow over 3 months
  • •local tenderness on palpation over the lateral epicondyle
  • •positive Mill's sign
  • •lateral elbow pain progression on resisted wrist and/or middle finger extension
  • •involved in working life

排除标准

  • •bilateral symptoms or simultaneous medial epicondylitis
  • •verified or suspected cervical radiculopathy or affected limb neuropathy
  • •congenital or acquired deformities of the elbow
  • •previous surgery of the elbow
  • •infection, dislocation, tendon ruptures, or fractures in the area
  • •systemic musculoskeletal or neurological disorders, incl. rheumatic diseases and fibromyalgia
  • •allergy, antibodies or other contraindications for botulinum toxin
  • •severe depression, chronic pain syndrome or somatisation disorder
  • •ongoing retirement process
  • •pregnancy or breastfeeding
  • •current participation in other clinical trials

研究组 & 干预措施

Active strength training and stretching

Active Comparator

Active strength training and stretching

干预措施: Active strength training and stretching (Behavioral)

Botulinum toxin type A injections

Active Comparator

Botulinum toxin type A injections

干预措施: Botulinum toxin type A (Botox®, Allergan) (Drug)

结局指标

主要结局

Pain, 100 mm visual analogue scale, change from baseline

时间窗: 0, 6, 13, 26, 39, 52 weeks

Grip strength (pain free and maximal), hydraulic hand dynamometer, change from baseline

时间窗: 0, 6, 13, 26, 39, 52 weeks

次要结局

  • Days in sick leave(0, 6, 13, 26, 39, 52 weeks)
  • Treatment adverse effects(0, 6, 13, 26, 39, 52 weeks)
  • Isometric wrist extension and flexion strength, digital hanging scale with rigid bench frame, change from baseline(0, 6, 13, 26, 39, 52 weeks)
  • Economic evaluation of interventions, direct and indirect costs(0, 6, 13, 26, 39, 52 weeks)
  • General improvement, 7-point Likert scale(0, 6, 13, 26, 39, 52 weeks)
  • Experienced disability, 100 mm visual analogue scale, change from baseline(0, 6, 13, 26, 39, 52 weeks)
  • Experienced forearm pain and disability, The Patient-Rated Tennis Elbow Evaluation (PRTEE)(0, 6, 13, 26, 39, 52 weeks)

研究者

发起方
Seinajoki Central Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aki Vainionpaa

Specialist in Physical Medicine and Rehabilitation

Seinajoki Central Hospital

研究点 (1)

Loading locations...

相似试验